Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
7.0
7.8
Journals
Vaccines
Special Issues
Trust in COVID-19 Vaccines, Policies, and Regulations
share announcement

Trust in COVID-19 Vaccines, Policies, and Regulations

A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "COVID-19 Vaccines and Vaccination".

Deadline for manuscript submissions: closed (31 December 2023) | Viewed by 2727

Special Issue Editors

Dr. Xiaoshan Austin Li

E-Mail Website
Guest Editor
Department of Communication, Faculty of Humanities and Social Sciences, Beijing Normal University-Hong Kong Baptist University United International College, Zhuhai 519087, China
Interests: public health; information behavior; risk information seeking; consumer health marketing
Dr. Katharine Hubbard

E-Mail Website
Guest Editor
Mass Communication Department, Sam Houston University, 1905 University Ave, Huntsville, TX 77340, USA
Interests: health communication; stigma; practitioner-consumer knowledge gaps

Special Issue Information

Dear Colleagues,

Since its outbreak in late 2019, SARS-CoV-2 (COVID-19) has set off unprecedented chaos worldwide: with millions of lives taken away, the highly mutable virus presents the world with great uncertainty. Countries across the globe raced to create vaccines as countermeasures, but vaccine acceptance varied country by country. Nearly three years into the pandemic, the development of COVID-19 vaccines is still evolving, and so do people’s trust in COVID-19 vaccines and related technologies. In addition, there are significant variations in regulatory policies for COVID-19 vaccines (e.g., requirements and distributions) at different levels, which may have left many vulnerable. We intend to dedicate this Special Issue to facilitating discussions that enfold efforts toward building vaccine confidence among people and shaping regulatory policies.

Dr. Xiaoshan Austin Li
Prof. Dr. Katharine Hubbard
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • COVID-19 vaccines and vaccinations
  • vaccine technology
  • trust in vaccines
  • trust in vaccine technology
  • policy
  • regulations
  • COVID-19

Published Papers (1 paper)

Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Research

39 pages, 727 KiB  
Article
Understanding the COVID-19 Vaccine Policy Terrain in Ontario Canada: A Policy Analysis of the Actors, Content, Processes, and Context
by Bara’ Abdallah AlShurman, Moses Tetui, Agnes Nanyonjo, Zahid Ahmad Butt, Nancy M. Waite, Elizabeth Vernon-Wilson, Ginny Wong and Kelly Grindrod
Vaccines 2023, 11(4), 782; https://doi.org/10.3390/vaccines11040782 - 31 Mar 2023
Cited by 2 | Viewed by 2435
Abstract
(1) Background: Canada had a unique approach to COVID-19 vaccine policy making. The objective of this study was to understand the evolution of COVID-19 vaccination policies in Ontario, Canada, using the policy triangle framework. (2) Methods: We searched government websites and social media [...] Read more.
(1) Background: Canada had a unique approach to COVID-19 vaccine policy making. The objective of this study was to understand the evolution of COVID-19 vaccination policies in Ontario, Canada, using the policy triangle framework. (2) Methods: We searched government websites and social media to identify COVID-19 vaccination policies in Ontario, Canada, which were posted between 1 October 2020, and 1 December 2021. We used the policy triangle framework to explore the policy actors, content, processes, and context. (3) Results: We reviewed 117 Canadian COVID-19 vaccine policy documents. Our review found that federal actors provided guidance, provincial actors made actionable policy, and community actors adapted policy to local contexts. The policy processes aimed to approve and distribute vaccines while continuously updating policies. The policy content focused on group prioritization and vaccine scarcity issues such as the delayed second dose and the mixed vaccine schedules. Finally, the policies were made in the context of changing vaccine science, global and national vaccine scarcity, and a growing awareness of the inequitable impacts of pandemics on specific communities. (4) Conclusions: We found that the triad of vaccine scarcity, evolving efficacy and safety data, and social inequities all contributed to the creation of vaccine policies that were difficult to efficiently communicate to the public. A lesson learned is that the need for dynamic policies must be balanced with the complexity of effective communication and on-the-ground delivery of care. Full article
(This article belongs to the Special Issue Trust in COVID-19 Vaccines, Policies, and Regulations)
►▼ Show Figures

Figure 1

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-1
Back to TopTop